Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)
AGENCY
HHS-NIH11
PROGRAM
Discretionary
AMOUNT
Up to $400K
CLOSES
Nov 5, 2028
Description
The purpose of this Notice of Funding Opportunity (NOFO) is tofurther elucidate the mechanisms of early immune development in utero, during the early post-natal period and during early childhood in neonates, infants, and children and adolescents with or without in-utero exposure to HIV or Anti-Retroviral Therapeutics (ART).This initiative aims to understand intricate mechanisms of immune cells at the maternal-fetal interface, T and B cell development and maturation in offspring, and local immune responses and the role of systemic immunity.
Eligibility
Private institutions of higher education; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; City or township governments; Public housing authorities/Indian housing authorities; Native American tribal governments (Federally recognized); County governments; Independent school districts; For profit organizations other than small businesses; Others (see text field entitled "Additional Information on Eligibility" for clarification); State governments; Special district governments; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Small businesses; Native American tribal organizations (other than Federally recognized tribal governments); Public and State controlled institutions of higher education
Contact
Additional details
- Funding instrument
- Grant
- Cost sharing required
- No
- Archived
- Dec 5, 2028
Opportunity number: PAR-25-362
Search this number on Grants.gov for the official listing.